Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1983 2
1985 2
1986 2
1987 3
1988 1
1989 2
1990 4
1991 3
1993 2
1994 3
1995 3
1996 5
1997 2
1998 1
1999 2
2000 1
2001 2
2002 1
2004 1
2005 3
2006 1
2007 1
2009 3
2011 2
2012 4
2013 4
2014 1
2015 2
2016 3
2017 2
2018 8
2019 5
2020 5
2021 7
2022 6
2023 4
2024 1
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 41766112

101 results

Results by year

Filters applied: . Clear all
Page 1
Identification of immune reconstitution and hematopoiesis restoration by scRNA-seq in bone marrow of multiple myeloma patients treated with high-dose melphalan following auto-HSCT.
Li Q, Wang Y, Yuan H, Cai Q, Zhao L, Lin L, Gao S, Chen L, Zhang Z, Ma J, Liu S, Cao Z, Zhao H, Wang Y, Li S, Lv P, Zhang H, Wang G, Yang G, Zhang X, Wang Y. Li Q, et al. Cancer Biol Med. 2026 Feb 27;23(2):247-51. doi: 10.20892/j.issn.2095-3941.2025.0585. Cancer Biol Med. 2026. PMID: 41766112 Free PMC article. No abstract available.
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M, Gay F, Beksac M, Pantani L, Petrucci MT, Dimopoulos MA, Dozza L, van der Holt B, Zweegman S, Oliva S, van der Velden VHJ, Zamagni E, Palumbo GA, Patriarca F, Montefusco V, Galli M, Maisnar V, Gamberi B, Hansson M, Belotti A, Pour L, Ypma P, Grasso M, Croockewit A, Ballanti S, Offidani M, Vincelli ID, Zambello R, Liberati AM, Andersen NF, Broijl A, Troia R, Pascarella A, Benevolo G, Levin MD, Bos G, Ludwig H, Aquino S, Morelli AM, Wu KL, Boersma R, Hajek R, Durian M, von dem Borne PA, Caravita di Toritto T, Zander T, Driessen C, Specchia G, Waage A, Gimsing P, Mellqvist UH, van Marwijk Kooy M, Minnema M, Mandigers C, Cafro AM, Palmas A, Carvalho S, Spencer A, Boccadoro M, Sonneveld P. Cavo M, et al. Lancet Haematol. 2020 Jun;7(6):e456-e468. doi: 10.1016/S2352-3026(20)30099-5. Epub 2020 Apr 30. Lancet Haematol. 2020. PMID: 32359506 Clinical Trial.
High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
Cesaro S, Meloni G, Messina C, Pillon M, Proglia A, Lanino E, Caniggia M, Bagnulo S, Pession A, Locatelli F; Italian Pediatric Group for Bone Marrow Transplantation. Cesaro S, et al. Bone Marrow Transplant. 2001 Jul;28(2):131-6. doi: 10.1038/sj.bmt.1703122. Bone Marrow Transplant. 2001. PMID: 11509930 Clinical Trial.
101 results